Nutrition and Health Sciences, Department of

 

Document Type

Article

Date of this Version

2012

Citation

PLoS ONE 7(4): e34921

Comments

Copyright 2012 Wang et al

Open access

doi:10.1371/journal.pone.0034921

Abstract

Activation of p53 function leading to cell-cycle arrest and/or apoptosis is a promising strategy for development of anticancer therapeutic agents. Here, we describe a novel mechanism for stabilization of p53 protein expression via activation of the orphan nuclear receptor, RORa. We demonstrate that treatment of cancer cells with a newly described synthetic ROR agonist, SR1078, leads to p53 stabilization and induction of apoptosis. These data suggest that synthetic ROR agonists may hold utility in the treatment of cancer.

Share

COinS